Market Insights

The global topical pain relief market is estimated to grow from USD 10.68 billion in 2023 to USD 14.43 billion by 2028 at a CAGR of 6.2% during the forecast period.

Wish to know more about the report? Click here to get a free sample.

What is topical pain relief?

Topical pain relief medicines are directly applied to the epidermal layer of the skin in the area of pain or inflammation. These topical pain relief products are mainly developed to relieve pain use the skin as the medium for drug administration and exert major action at the specific skin site and in the central nervous system.

Moreover, these chemical formulations are anesthetic or analgesic agents, which are applied on or around the painful site. The main focus is to provide a slow and gradual release of pain relief medication into the bloodstream by keeping the blood levels relatively constant for some time.

Key Players

Key players operating in the global topical pain relief market are-

• Johnson & Johnson (The U.S),
• Novartis AG (Switzerland),
• GlaxoSmithKline Plc. (UK),
• Pfizer Inc. (The U.S),
• Reckitt Benckiser Group Plc. (UK),
• Sanofi S.A. (France),
• Topical BioMedics, Inc. (The U.S),
• AdvaCare Pharma (India),
• Sun Pharmaceutical Industries Ltd. (India), and
• Nestle S.A. (Switzerland).

Market Dynamics

The growing prevalence of arthritis and other bone-related medical conditions, and diabetic neuropathy results in pain, thereby acting as a key driver.

• The surge in the adoption of topical pain relief products due to fewer side effects in comparison to oral pain relief drugs, the rise in the need for topical pain relief among sportsmen, and the growing geriatric population worldwide are other factors augmenting the market growth.
• However, this pain relief formulation can result in irritated skin and it also possesses a strong odor, thus creating a hindrance to the market expansion.

Segment Analysis

Therapeutic Class Trends

By therapeutic class, the topical pain relief market has been bifurcated into non-opioids and opioids.

• Under these, the non-opioids segment held the largest market share in 2022 and is projected to register a healthy CAGR during the review period.
• This is mainly attributed to its high preference for opioid drugs for treating mild to moderate pain.
• Also, it has relatively fewer side effects in comparison to opioids, further boosting the segment growth.

Regional Trends

By region, the North America market garnered the largest market share in 2022 and is likely to grow at a steady CAGR during the assessment period.

• This is mainly ascribed to the increasing adoption of over-the-counter pain relief products and early approval of topical pain relief medications in this region.
• Also, the presence of major product manufacturers in the region further boosts the regional market growth.

COVID-19 Impact on Global Topical Pain Relief Market

The outbreak of the COVID-19 virus has substantially affected the topical pain relief industry. A large number of clinics and pain services have witnessed a significant decline in the number of patient visits during the pandemic. In addition, most chronic pain services were considered non-urgent, both elective interventional and outpatient procedures were partially shut down or completely stopped during the COVID-19 period to curb the risk of the viral spread.

Target Audience

The following is a list of the customers that the Topical Pain Relief market aims to convert the most:

• Topical pain relief companies
• Topical pain relief vendors
• R&D companies
• Hospitals
• Drug manufacturing companies

Critical Questions Answered in the Report

• What are the key trends in the global topical pain relief market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on the global topical pain relief market?
• What are the key strategies adopted by the major vendors to lead in the global topical pain relief market?
• What is the market share of the top vendors?

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market. 

What Deliverables Will You Get in this Report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Options

Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected].